1

our mission

"Our mission is to bring healthcare of International standards within the reach of every individual. We are committed to the achievement and maintenance of excellence in education, research and healthcare for the benefit of humanity".

Dr. Prathap C Reddy, Founder and Chairman – Apollo Hospitals inaugurates South Asia’s First Digital PET-CT at the Apollo Proton Cancer Centre, Chennai

Date: 2019-05-27
Location: Chennai


The state-of-the-art Digital PET CT - Biograph Vision 600™ scanning machine is a radioactive diagnostic agent used in positron emission tomography (PET) imaging.  The inauguration was done in the presence of Dr. Prathap C Reddy, Founder and Chairman – Apollo Hospitals, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals Group and Mr.  Vivek Kanade, Executive Director, Siemens Healthineers India.



With nearly a million new cancer cases diagnosed per annum in India, staging disease more accurately and defining treatment strategies better is the need of the hour. With the introduction of Biograph Vision 600™ in India, will help deliver the right treatment to the right patient and at the right time.


“Biograph Vision 600 is designed for improved accuracy, performance, and reproducibility to deliver a whole new world of precision in PET/CT imaging. With the market’s fastest time-of-flight and highest effective sensitivity, Biograph Vision helps reduce scan time and injected dose, reducing patient exposure to radiation.


PET CT is indispensable as a diagnostic and prognostic tool in the assessment of patient response to cancer therapy and cancer recurrence. The Biograph Vision 600from Siemens Healthineers enables a better understanding of disease progression and treatment resistance, to define treatments that can be precisely tailored for patients.


Dr. Prathap C Reddy, Chairman, Apollo Hospitals Group said, “Our patient centric ethos has always motivated us to invest in the best available for our patients and Apollo has been at the forefront of introducing cutting edge technologies in India and the region. Apollo Proton Cancer Centre in Chennai has ushered new hope for over 3.5 billion people, who earlier would have had to travel to the western world to access Proton Therapy, the world’s most advanced radiation therapy.  Increasingly Proton Therapy is becoming the standard of care for several cancers and its unique edge of minimal side effects is transforming quality of cancer survivorship.”


Speaking about the benefits, Ms. Suneeta Reddy, Managing Director, Apollo Hospitals added, “The DNA of Apollo Hospitals is clinical excellence and achieving clinical outcomes on par with the world’s best centres. Each of our investments including the Siemens Biograph Vision 600 at our new Apollo Proton Cancer Centre underscores this spirit and commitment to provide an international standard of care for our patients.”


The benefits of the Digital PET-CT Scanner in Oncology Care




  • Reduces radiation dose to patient

  • Can help detect cancer early

  • Faster scan time and is comfortable for patients

  • More sensitive for small tumours in Oncology

  • Best clinical outcomes

  • Improved accuracy in imaging and clarity

  • Improves patient Care in Oncology

  • Well suited to find recurrent disease

  • Increased sensitivity of the digital detector improves image quality,

  • While short scan times make the patient more comfortable and less prone to move. This reduces the likelihood of motion artifacts that can degrade images

  • 4D Gating for RT planning



The Biograph Vision Model Digital PET CT: Exclusive features




  • First Digital parametric PET imaging in South East Asia

  • Industry’s fastest Time-of-flight at 214 ps.

  • Market’s highest sensitivity at 100 cps/kBq

  • Wide bore PET/CT with 78 cm bore size.

  • Industry best resolution that helps in detection of small lesion

  • Flow Motion and Parametric PET imaging



The level of details provided by the allows doctors to more accurately stage the disease and provide patients with a treatment regimen that achieves better outcomes. There by smaller lesions missed in the conventional PET-CT would be identified.



APOLLO cancer FOUNDATION

A mission to make cancer care in India more inclusive and accessible.

VOLUNTEER AT APCC

Participate and pledge your support to make cancer conquerable.

Help us set a new world
standard in care

X

Get in touch

Please fill out the information so we can get back to you


Please select who you are?
Please enter your first name.
Please enter your last name
Please enter your city.
Please enter your country
Please select language
Please select your communication preference
Please enter valid mobile no
Please enter valid email
Invalid Input
Enter the Verification Code
RefreshInvalid captcha